MedPath

dopavision GmbH

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:1

Trial Phases

1 Phases

Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (100.0%)

MyopiaX Treatment for the Reduction of Myopia Progression in Children and Adolescents: Safety and Efficacy Investigation

Not Applicable
Completed
Conditions
Myopia
First Posted Date
2021-07-19
Last Posted Date
2024-10-28
Lead Sponsor
Dopavision GmbH
Target Recruit Count
124
Registration Number
NCT04967287
Locations
🇩🇪

Suedblick GmbH, Augsburg, Germany

🇩🇪

MVZ Makula-Netzhaut-Zentrum Breyer Kaymak Klabe, Düsseldorf, Germany

🇩🇪

BeyondEye Clinic, Köln, Germany

and more 7 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.